AAN

Can the EpiFinder App Help Diagnose Epilepsy More Quickly?

May 08, 2018

Article

EpiFinder, a mobile health application, predicted either an epilepsy syndrome or alternative diagnosis with 86.8% accuracy.

Paulo Fontoura, MD, PhD: Ocrelizumab, Advanced Measures for PPMS

May 02, 2018

Video

Genentech's global head of Neuroscience clinical development detailed the company's commitment to treating the progressive form of multiple sclerosis.

Q&A: Jacqueline Montes, PT, on Spinraza's Improvements for SMA Fatigability

April 29, 2018

Article

Montes' team found benefits in motor function, walking ability, and fatigue in patients to undergo nusinersen (Spinraza) for spinal muscular atrophy.

Rachelle Doody, MD, PhD: CREAD and GRADUATE trials for Alzheimer's

April 29, 2018

Article

The Global Head of Neurodegeneration for Genentech talks about the progress of 2 promising monoclonal antibodies.

Rick Rudick, MD: Progressing Collaborative, Evidence-Based MS Care

April 28, 2018

Video

The vice president of Development Sciences for Biogen shared developments to come of the international MS PATHS collaboration.

Children with SMA1 Show Remarkable Progress on Gene Therapy

April 27, 2018

Article

Children receiving AVXS-101 have shown such improvement that researchers are calling for an update to the CHOP-INTEND scale used to track their progress.

Teriflunomide Therapy Switch Improves Patient Satisfaction in Relapsing MS

April 26, 2018

Article

Patients from 2 demographically-different studies switching from interferon therapy to Aubagio reported similar improvements.

Alfred Sandrock, MD, PhD: Progressing Parkinson's Therapies and What They Target

April 25, 2018

Video

The executive vice president and chief medical officer of Biogen explained how crucial it is for potential DMTs to attacki the alpha-synuclein protein.

Tad Seifert, MD: CTE, Sports Neurology, and the Future of the NFL

April 25, 2018

Article

The director of the Sports Neurology Program at Norton Healthcare and head of the NCAA Headache Task Force discussed trends in his popularizing field.

Galcanezumab Reduced Monthly Migraine Headache Days for Treatment-Resistant Cases

April 24, 2018

Article

Patients who had previously failed ≥2 preventative migraine treatments were effectively treated with galcanezumab, especially when compared to placebo.

x